Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands – Business Wire

HONG KONG--(BUSINESS WIRE)--Global Cord Blood Corporation (NYSE: CO) (GCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that an order was made by the Grand Court of the Cayman Islands (Grand Court) on September 22, 2022 (the Order) appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited as the Joint Provisional Liquidators of the Company (the Joint Provisional Liquidators). Upon the making of the Order, the powers of the directors of the Company are suspended. Blue Ocean Structure Investment Company Limited, a shareholder of the Company, filed a petition on August 22, 2022 in the Grand Court requesting the appointment

Read more
Biobanking Market Size to Surge at the CAGR of 5.9% from 2022-2031 – Digital Journal

Biobanking Market Introduction The term biobanking is often misused to refer to any collection of human biological specimens (biospecimens), regardless of the standards established for various tissue collection procedures or requirements pertaining to ethical and legal considerations. The process of collecting bodily fluids or tissue samples for usage in research to better understand health and disease is referred to as biobanking. Biobank is a sizable collection of biospecimens that are kept primarily for usage in health and medical research, and are linked to pertinent personal and health data (such aselectronic medical record, family history, lifestyle, and genetic information). The National Centre for Advanced Research and Excellence in Heart Failure (CARE-HF) at SCTIMST was established by ICMR to expand research in the field, as heart failureemerged as a significant health issue in India. One of the projects key components is the Heart Failure Biobank, which received funding of US$ 85,000 to build cutting-edge storage facilities.

Read more
Stem Cell Banking Solutions | Hope Biosciences

Our expertise lies in the ability to multiply and bank one's own cells for use in the future. Instead of imagining the potential, we decided to put them to the test.Trust your healthyour cellsto the company determined to make the availability of your cells, a reality.

Read more
Stem Cell Therapy Market worth $558 million by 2027 Exclusive Report by MarketsandMarkets – Benzinga

Chicago, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Stem Cell Therapy Marketis projected to reach USD 558 million by 2027 from USD 257 million in 2022, at a CAGR of 16.8% during the forecast period, according to a new report by MarketsandMarkets. Key drivers of the stem cell therapy market include increase in stem cell research funding, expanding number of clinical trials related to stem cell therapies, and growing number of GMP-certified cell therapy production facilities. However, high costs associated with the development of stem cell therapy along with the ethical concerns related to embryonic stem cells are likely to hamper the market growth to a certain extent.

Read more
Stem Cell Banking Market Analysis, 2031: Advancements in the field of Regenerative Medicine – BioSpace

The demand within the global stem cell banking market is growing on account of advancements in the field of regenerative medicine. The medical fraternity has become extremely focused towards the development of artificial tissues that can infuse with the human body. Furthermore, medical analysis and testing has gathered momentum across biological laboratories and research institutes.

Read more
Stem Cell Therapy Market worth $558 million by 2027 Exclusive Report by MarketsandMarkets – GlobeNewswire

Chicago, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Stem Cell Therapy Marketis projected to reach USD 558 million by 2027 from USD 257 million in 2022, at a CAGR of 16.8% during the forecast period, according to a new report by MarketsandMarkets. Key drivers of the stem cell therapy market include increase in stem cell research funding, expanding number of clinical trials related to stem cell therapies, and growing number of GMP-certified cell therapy production facilities. However, high costs associated with the development of stem cell therapy along with the ethical concerns related to embryonic stem cells are likely to hamper the market growth to a certain extent

Read more
Cord Blood Banking Services Market Size Estimated to Reach $3.6 Billion By 2027 at a CAGR of 11.8% During Forecast Period 2022-2027. – Digital Journal

Cord Blood Banking Services Market Size is estimated to reach $3.6 billion by 2027. Furthermore, it is poised to grow at a CAGR of 11.8% over the forecast period of 2022-2027. Cord blood transplant is used to cure the various types of serious conditions such as cancer of blood like leukemia, lymphoma; bone marrow failure, sickle cell anemia, thalassemia, immunodeficiency, and metabolic disorders. Cord Blood Banking Services Market Size isestimated to reach $3.6 billionby 2027. Furthermore, it is poisedto grow at a CAGR of 11.8%over the forecast period of 2022-2027.

Read more
Applied StemCell expands manufacturing facility to support cell and gene therapies – BioPharma-Reporter.com

The Milpitas, California cell and gene therapy CRO/CDMO, whose focus is on supporting the research community and biotechnology industry in developing and manufacturing cell and gene products, has successfully carried out cell banking and product manufacturing projects in its current cGMP suite and is now set on building 4 additional cGMP cleanrooms, cryo-storage space, and a process development and QC/QA space. The expansion of the facility will increase its cell banking and cell product manufacturing capacity and allow ASCs team of experts to work simultaneously on multiple manufacturing projects such as iPSC generation, gene editing, differentiation, and cell bank manufacturing for safe and efficacious therapeutic products. ASC estimates it will be able to take on four times as many projects once the expansion is complete early next year.

Read more